raremaprare-disease reference indexOrphadata 2026-06-23 · HPO 2026-09-01
ORPHA:309246

GM2 gangliosidosis, AB variant

Synonyms: Hexosaminidase activator deficiency

Type
Disease
Group
Disorder
Inheritance
Autosomal recessive
Age of onset
Infancy
Status
active

GM2 gangliosidosis, AB variant is an extremely rare, severe genetic disorder characterized by progressive neurological decline due to ganglioside activator deficiency.

1

Names in Orphadata languages

12 of 12 languages
LangNameSynonyms
enGM2 gangliosidosis, AB variantHexosaminidase activator deficiency
frGangliosidose à GM2 variant ABDéficit en activateur de l'hexosaminidase
deGM2-Gangliosidose, AB-VarianteHexosaminidase-Aktivator-Mangel
esGangliosidosis GM2, variante ABDeficiencia del activador de hexosaminidasa
itGM2-gangliosidosi, variante ABDeficit dell'attivatore di esosaminidasi
nlGM2-gangliosidose, AB-variantHexosaminidaseactivatordeficiëntie
ptGangliosidose-GM2, variante AB
plGangliozydoza GM2, wariant ABNiedobór aktywatora heksozoaminidazy
csGM2 gangliosidóza, varianta ABDeficit aktivátoru hexosaminidázy
ukГангліозидоз GM2, варіант ABДефіцит активатора гексозамінідази
zhAB型GM2神经节苷脂贮积症己糖胺酶激活剂缺乏
trGM2 gangliosidoz, AB varyantıHekzosaminidaz aktivatör eksikliği

Definition in:

2

Cross-references

qualifier = Orphanet mapping relation
SourceCodeQualifierICD relationValidation
OMIM272750Evalidated
ICD-10E75.0NTBTattributedvalidated
ICD-115C56.00NTBTindexvalidated
MONDO0010099Evalidated
UMLSC0268275Evalidated

E exact · NTBT this ORPHAcode is narrower than the target · BTNT broader than the target · ND not decided.

3

Classification

Preferential parent (Orphanet linearisation):

Parents in the classifications (1):

No children.

4

Genes

1 direct
GeneAssociationStatusHGNCEnsemblOMIMLocusNameSource of validation
GM2ADisease-causing germline mutation(s) inAssessedHGNC:4367ENSG000001967436131095q33.1ganglioside GM2 activator8900233[PMID]
5

Prevalence and incidence

2 records
TypeClassValueAreaQualificationValidationSource
Cases/families10 casesWorldwideCase(s)Validated26082327[PMID]
Point prevalence<1 / 1 000 000—WorldwideClass onlyValidatedORPHANET_26082327[PMID]

Value is Orphadata's ValMoy: the mean estimate per 100 000 for prevalence and incidence, the number of cases or families for case reports.

6

HPO phenotypes

25 annotations · validated 2017-07-19
HPOTerm (as annotated by Orphanet)Diagnostic
Very frequent (99-80%)
HP:0100852Abnormal fear/anxiety-related behavior
HP:0007256Abnormal pyramidal sign
HP:0008936Axial hypotonia
HP:0002059Cerebral atrophy
HP:0100543Cognitive impairment
HP:0002376Developmental regression
HP:0001332Dystonia
HP:0002267Exaggerated startle response
HP:0010780Hyperacusis
HP:0001347Hyperreflexia
HP:0002180Neurodegeneration
HP:0002478Progressive spastic quadriplegia
HP:0004322Short stature
Frequent (79-30%)
HP:0012547Abnormal involuntary eye movements
HP:0000739Anxiety
HP:0010729Cherry red spot of the macula
HP:0002072Chorea
HP:0030904Glabellar reflex
HP:0000719Inappropriate behavior
HP:0002371Loss of speech
HP:0008897Postnatal growth retardation
HP:0002476Primitive reflex
HP:0001250Seizure
Occasional (29-5%)
HP:0002200Pseudobulbar signs
HP:0030081Punctate periventricular T2 hyperintense foci

Run the differential on the 12 obligate / very frequent terms

Annotation source: 26203402[PMID]_9932959[PMID]_6801612[PMID]_174379[PMID]

7

Sources for this card